Stocks to Watch on April 20, 2026: HDFC Bank, ICICI Bank, Yes Bank, Mastek, EMS and Others

In the previous trading session, benchmark indices traded cautiously as investors tracked quarterly earnings, global cues and domestic corporate developments. 

Market participants are expected to closely monitor earnings releases, regulatory inspections, project wins and strategic announcements that could influence stock-specific movements in today’s session. 

Quarterly Earnings in Focus 

Several companies including HDFC Bank, ICICI Bank and Yes Bank reported their March quarter performance, highlighting steady growth in profitability and improving asset quality. 

HDFC Bank reported a 9.1% year-on-year rise in profit, while ICICI Bank posted an 8.5% increase. Yes Bank stood out with a sharp 44.7% jump in profit, supported by strong growth in net interest income and lower provisions. 

Meanwhile, Jio Financial Services reported a decline in profit despite strong revenue growth, indicating margin pressures. 

Mastek delivered a robust performance with over 30% growth in profit, while media and cable companies such as Network18 Media & Investments and Hathway Cable & Datacom reported mixed results. 

Stocks to Watch 

H G Infra Engineering Ltd 

H G Infra Engineering has incorporated a special purpose vehicle for a road project worth ₹1,582.11 crore in Odisha, awarded by the National Highways Authority of India, strengthening its infrastructure pipeline. 

EMS Ltd 

EMS emerged as the lowest bidder for two construction projects from UP Jal Nigam with a combined value exceeding ₹200 crore, supporting order book visibility. 

Lupin Ltd 

Lupin received a Form 483 with three observations following a US FDA inspection of its Somerset facility, which may be tracked by investors. 

Amagi Media Labs 

Amagi Media Labs announced a strategic collaboration to enhance cloud-based content production capabilities, signalling growth in media technology solutions. 

Cipla Ltd 

Cipla underwent a US FDA inspection at its Goa facility and received two observations, which could remain in focus. 

Aurobindo Pharma Ltd 

Aurobindo Pharma received final USFDA approval for a cough treatment drug, expanding its portfolio in the US generics market. 

Trent Ltd 

Trent will consider a bonus share issue and fundraising plans, along with announcing annual results on April 22. 

Bharat Heavy Electricals Ltd (BHEL) 

BHEL withdrew a project acceptance and initiated legal proceedings to recover dues, highlighting ongoing contractual challenges. 

Lemon Tree Hotels Ltd 

Lemon Tree Hotels signed a new hotel agreement in Gujarat, indicating continued expansion in the hospitality segment. 

Zee Entertainment Enterprises Ltd 

Zee Entertainment Enterprises approved an investment in Phantom Digital Effects, reflecting strategic expansion in digital content capabilities.\ 

Read More: Lakshya Powertech Share Price in Focus; Bags ₹642 Crore O&M Contract from Vedanta! 

Bulk Deals 

Bharat Wire Ropes Ltd 

Bharat Wire Ropes witnessed significant stake purchases by Lloyds Group entities, while a fund entity partially exited its position. 

Ind-Swift Laboratories Ltd 

Large stake sales by HCP Investments and selective buying by institutional investors were recorded in Ind-Swift Laboratories, indicating active investor participation. 

Other Developments 

Additional companies such as Bank of Maharashtra, PNB Housing Finance and others are set to announce quarterly earnings today, which may drive stock-specific volatility. 

Stocks including SAIL and Sammaan Capital are currently under the F&O ban, and trading activity in these counters may remain restricted. 

Conclusion 

Earnings performance, regulatory updates, strategic investments and bulk deal activity are expected to drive market sentiment and stock-specific action in today’s trading session. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.